NYSE$THC
Tenet Healthcare Corp · Q2 2020 earnings
Q2 2020 earnings · · Investor relations
Briefing
Tenet Healthcare's performance was impacted by COVID-19 and supported by federal stimulus.
Tenet Healthcare reported net income from continuing operations available to common shareholders of $88 million, or $0.83 per diluted share, in 2Q20. The company's results were significantly impacted by the COVID-19 pandemic, but were partially offset by cost-reduction initiatives and grant income from stimulus relief funds. The financial support of the CARES Act provided an important bridge to minimize the financial crisis the pandemic created, allowing uninterrupted care for our patients and communities.
- Net income from continuing operations available to common shareholders of $88 million, or $0.83 per diluted share, in 2Q20 versus net income from continuing operations of $24 million, or $0.23 per diluted share, in 2Q19
- Consolidated Adjusted EBITDA of $732 million in 2Q20 versus $669 million in 2Q19
- Federal stimulus support received was critical in addressing pandemic challenges, allowing uninterrupted response across our care facilities
- Experienced pronounced volatility in monthly volumes associated with COVID-19 during 2Q20, including restrictions on elective procedures, with April lows followed by substantial improvement in May and June
Headline financials
Revenue & EPS history
Tenet Healthcare · Revenue · Quarterly
$3.65B
Revenue by segment
Tenet Healthcare · $3.46B total across 2 segments · Q2 2020
- Hospital Operations$3.09B—89.4%
- Ambulatory Care$368M—10.6%
Forward guidance
On April 2, 2020, Tenet withdrew its 2020 Financial Outlook due to the impact of the COVID-19 pandemic upon the Company's ability to forecast its results with precision in the near term.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2020
-1.0%
Avg return
Earnings day
+1.0%
Avg return
5 days after
+3.0%
Avg return
30 days after
49%
33 / 68 earnings
Positive
+13.3%
Q3 2024
Best reaction
-31.1%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.7% | +3.8% | -2.8% | |
| Q4 2025 | -0.7% | +6.4% | +29.3% | |
| Q3 2025 | -5.3% | -4.5% | +0.6% | |
| Q2 2025 | +0.3% | +3.6% | +12.2% | |
| Q1 2025 | +0.2% | -9.6% | +7.4% | |
| Q4 2024 | -9.1% | -4.0% | -11.6% | |
| Q3 2024 | +13.3% | +11.9% | +1.8% | |
| Q2 2024 | +8.0% | +10.2% | +18.6% | |
| Q1 2024 | -0.7% | -2.8% | +6.8% | |
| Q4 2023 | -0.0% | +6.9% | +14.0% | |
| Q3 2023 | +1.1% | +3.4% | +26.8% | |
| Q2 2023 | +3.3% | +0.2% | +5.4% | |
| Q1 2023 | +1.5% | +5.6% | +27.3% | |
| Q4 2022 | -3.2% | +13.8% | -3.3% | |
| Q3 2022 | -31.1% | -24.0% | -17.2% | |
| Q2 2022 | +7.8% | +7.9% | +7.9% | |
| Q1 2022 | -0.3% | -8.0% | -16.6% | |
| Q4 2021 | -5.3% | +12.1% | +23.0% | |
| Q3 2021 | +9.3% | +6.7% | +20.2% | |
| Q2 2021 | -0.7% | +1.6% | +3.0% | |
| Q1 2021 | -3.7% | -4.5% | +11.5% | |
| Q4 2020 | -5.1% | -4.7% | +6.3% | |
| Q3 2020 | +0.9% | +3.4% | +12.9% | |
| Q2 2020 | +0.6% | +10.1% | +10.6% | |
| Q1 2020 | -8.6% | +19.3% | +34.4% | |
| Q4 2019 | -14.5% | -23.2% | -47.4% | |
| Q3 2019 | +8.6% | +14.8% | +30.4% | |
| Q2 2019 | -3.8% | -5.0% | -7.9% | |
| Q1 2019 | +3.2% | +8.1% | -24.1% | |
| Q4 2018 | +11.5% | +21.6% | +16.5% | |
| Q3 2018 | -9.3% | -3.2% | -8.7% | |
| Q2 2018 | -15.6% | -15.9% | -17.4% | |
| Q1 2018 | -4.4% | +0.7% | -1.3% | |
| Q4 2017 | +7.7% | +13.7% | +23.6% | |
| Q3 2017 | +7.7% | +9.2% | +4.6% | |
| Q2 2017 | -14.8% | -16.2% | +2.3% | |
| Q1 2017 | -4.1% | -3.6% | -13.8% | |
| Q4 2016 | -12.2% | -4.5% | -18.5% | |
| Q3 2016 | -5.6% | -12.3% | -24.8% | |
| Q2 2016 | -9.9% | -10.2% | -21.9% | |
| Q1 2016 | -0.1% | — | — | |
| Q4 2015 | +5.4% | — | — | |
| Q3 2015 | +9.2% | — | — | |
| Q2 2015 | +2.1% | — | — | |
| Q1 2015 | -3.2% | — | — | |
| Q4 2014 | +1.0% | — | — | |
| Q3 2014 | -5.3% | — | — | |
| Q2 2014 | +4.8% | — | — | |
| Q1 2014 | +1.7% | — | — | |
| Q4 2013 | -6.3% | — | — | |
| Q3 2013 | -6.8% | — | — | |
| Q2 2013 | -7.0% | — | — | |
| Q1 2013 | +0.9% | — | — | |
| Q4 2012 | +3.5% | — | — | |
| Q3 2012 | +5.4% | — | — | |
| Q2 2012 | +11.8% | — | — | |
| Q1 2012 | +1.1% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q3 2011 | +4.9% | — | — | |
| Q2 2011 | -4.6% | — | — | |
| Q1 2010 | -6.3% | — | — | |
| Q1 2011 | +1.6% | — | — | |
| Q4 2008 | +3.0% | — | — | |
| Q3 2009 | +0.0% | — | — | |
| Q3 2010 | +0.0% | — | — | |
| Q2 2009 | +0.7% | — | — | |
| Q2 2010 | +0.7% | — | — | |
| Q4 2009 | +0.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro